Search research articles
Contact Us
Filters
Showing results (21-30 of 90) with videos related to
Page
of 9
Sort By:
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
April 28, 2019
[Optical coherence tomography angiography as a future diagnostic tool in sports medicine?]
Florian Alten, Pieter Nelis, Boris Schmitz, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
June 9, 2021
Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three-arm parallel randomized trial
Marc Teschler, Melina Heimer, Boris Schmitz, et al.
The Journal of Sports Medicine and Physical Fitness
|
May 8, 2019
Progressive high-intensity interval training (HIIT) is not superior to unmodified non-progressive HIIT in an uncontrolled setting
Boris Schmitz, Lothar Thorwesten, Andreas Klose, et al.
The Journal of Allergy and Clinical Immunology
|
February 9, 2018
Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion
Malte Lenders, Boris Schmitz, Stefan-Martin Brand, et al.
Scientific Reports
|
September 15, 2021
Longitudinal choriocapillaris changes in the presence of reticular pseudodrusen
Christoph R Clemens, Jost L Lauermann, Boris Schmitz, et al.
Journal of Science and Medicine in Sport
|
June 17, 2019
Normative Yo-Yo Intermittent Recovery Level 1 and Yo-Yo Intermittent Endurance Level 1 test values of boys aged 9-16years
Boris Schmitz, Carina Pfeifer, Kiana Kreitz, et al.
Frontiers in Medicine
|
June 30, 2025
Use of speleotherapy in patients with post-COVID-19 syndrome
René Garbsch, Mona Kotewitsch, Hendrik Schäfer, et al.
Research Quarterly for Exercise and Sport
|
February 1, 2020
Yo-Yo Intermittent Recovery Level 1 Test for Estimation of Peak Oxygen Uptake: Use Without Restriction?
Boris Schmitz, Carina Pfeifer, Lothar Thorwesten, et al.
Scientific Reports
|
March 11, 2018
ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA
Katrin Schelleckes, Boris Schmitz, Malte Lenders, et al.
Brain Communications
|
February 23, 2026
Assessment of dynamic cerebral blood flow changes during cognitive tasks in patients with post-COVID-19 syndrome
Dieter F Kutz, René Garbsch, Frank C Mooren, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 90) with videos related to
Sort By:
Page
of 9
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
April 28, 2019
[Optical coherence tomography angiography as a future diagnostic tool in sports medicine?]
Florian Alten, Pieter Nelis, Boris Schmitz, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
June 9, 2021
Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three-arm parallel randomized trial
Marc Teschler, Melina Heimer, Boris Schmitz, et al.
The Journal of Sports Medicine and Physical Fitness
|
May 8, 2019
Progressive high-intensity interval training (HIIT) is not superior to unmodified non-progressive HIIT in an uncontrolled setting
Boris Schmitz, Lothar Thorwesten, Andreas Klose, et al.
The Journal of Allergy and Clinical Immunology
|
February 9, 2018
Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion
Malte Lenders, Boris Schmitz, Stefan-Martin Brand, et al.
Scientific Reports
|
September 15, 2021
Longitudinal choriocapillaris changes in the presence of reticular pseudodrusen
Christoph R Clemens, Jost L Lauermann, Boris Schmitz, et al.
Journal of Science and Medicine in Sport
|
June 17, 2019
Normative Yo-Yo Intermittent Recovery Level 1 and Yo-Yo Intermittent Endurance Level 1 test values of boys aged 9-16years
Boris Schmitz, Carina Pfeifer, Kiana Kreitz, et al.
Frontiers in Medicine
|
June 30, 2025
Use of speleotherapy in patients with post-COVID-19 syndrome
René Garbsch, Mona Kotewitsch, Hendrik Schäfer, et al.
Research Quarterly for Exercise and Sport
|
February 1, 2020
Yo-Yo Intermittent Recovery Level 1 Test for Estimation of Peak Oxygen Uptake: Use Without Restriction?
Boris Schmitz, Carina Pfeifer, Lothar Thorwesten, et al.
Scientific Reports
|
March 11, 2018
ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA
Katrin Schelleckes, Boris Schmitz, Malte Lenders, et al.
Brain Communications
|
February 23, 2026
Assessment of dynamic cerebral blood flow changes during cognitive tasks in patients with post-COVID-19 syndrome
Dieter F Kutz, René Garbsch, Frank C Mooren, et al.
Page
of 9